In addition to comprehensive benchmarks from European hospitals and health care providers within the scope of effective laws and European-wide valid standards for data privacy protection, MEDSTAT S.A. provides comprehensive research-options in the area of:
- Risk-adjusted register studies
- Risk-adjusted prospective evaluations for different outcomes
- Health-economic studies in the area of pharmacy and medical devices industry
- Provision of methods on the basis of licensing and user agreements (MEDSTAT-Index and other)
Risk-adjusted outcome evaluation
With our risk-adjusted outcome evaluation we offer the analysis and assessment of clinically relevant endpoints.